Bendamustine Combined with Bortezomib Has Efficacy in Patients with Relapsed or Refractory Multiple Myeloma: A Phase 1/2 Study

被引：0
|
作者：
Berenson, James R.
Yellin, Ori
Bessudo, Alberto [1 ]
Boccia, Ralph V. [2 ]
Noga, Stephen J. [3 ]
Gravenor, Donald S. [4 ]
Patel-Donnelly, Dipti [5 ]
Siegel, Robert S. [6 ]
Kewalramani, Tarun [7 ]
Gorak, Edward J. [8 ]
Swift, Regina A. [9 ]
Mayo, Debra [10 ]
机构：
[1] San Diego Pacific Oncol Hematol Associates Inc, Encinitas, CA USA
[2] Ctr Canc & Blood Disorders, Bethesda, MD USA
[3] Weinberg Canc Inst Franklin Sq, Sect Hematol, Baltimore, MD USA
[4] Family Canc Ctr, Memphis, TN USA
[5] Virginia Canc Specialists PC, Fairfax, VA USA
[6] George Washington Univ, Med Ctr, Washington, DC 20037 USA
[7] Lahey Clin Med Ctr, Burlington, MA 01803 USA
[8] Geisinger Med Ctr, Danville, PA 17822 USA
[9] James R Berenson MD Inc, Los Angeles, CA USA
[10] Cephalon Inc, Frazer, PA USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：808 / 809
页数：2
相关论文
共 50 条
  • [41] BENDAMUSTINE, BORTEZOMIB AND DEXAMETHASONE (BVD) COMBINATION FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: AN INTERIM ANALYSIS OF A PHASE II STUDY
    Offidani, M.
    Corvatta, L.
    Caraffa, P.
    Liberati, A. M.
    Alesiani, F.
    Brunori, M.
    di Toritto, T. Caravita
    Gentili, S.
    Attolico, I.
    Mele, A.
    Pulini, S.
    Ballanti, S.
    Galimberti, S.
    Gozzetti, A.
    Coppetelli, U.
    Ledda, A.
    Leoni, P.
    HAEMATOLOGICA, 2012, 97 : 353 - 353
  • [42] A phase II study of a 1-hour infusion of romidepsin combined with bortezomib for multiple myeloma (MM) patients with relapsed or refractory disease
    Berenson, J. R.
    Yellin, O.
    Mapes, R.
    Eades, B.
    Abaya, C. D.
    Strayer, A.
    Nix, D.
    Swift, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Combination chemotherapy with bortezomib, bendamustine and prednisone for patients with refractory/relapsed multiple myeloma:: An unicentric retrospective trial
    Poenisch, W.
    Bourgeois, M.
    Wang, S. Y.
    Heyn, S.
    Jaekel, N.
    Braunert, L.
    Pfannes, R.
    Nehring, C.
    Nehring, C.
    Becker, C.
    Becker, C.
    Al Ali, H.
    Hensel, G.
    Niederwieser, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 432 - 432
  • [44] Phase Ib venetoclax combined with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.
    Moreau, Philippe
    Chanan-Khan, Asher Alban Akmal
    Roberts, Andrew Warwick
    Agarwal, Amit
    Facon, Thierry
    Kumar, Shaji
    Touzeau, Cyrille
    Diehl, Susan
    Cordero, Jaclyn
    Ross, Jeremy A.
    Munasinghe, Wijith
    Zhu, Ming
    Salem, Ahmed H.
    Leverson, Joel
    Maciag, Paulo Cesar
    Verdugo, Maria E.
    Harrison, Simon J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Bortezomib in Relapsed/Refractory Multiple Myeloma
    Shen, Z.
    Wang, L.
    Yan, H.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S62 - S62
  • [46] PANORAMA 2: A PHASE II STUDY OF PANOBINOSTAT IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED AND BORTEZOMIB-REFRACTORY MULTIPLE MYELOMA
    Richardson, P.
    Alsina, M.
    Weber, D.
    Coutre, S.
    Lonial, S.
    Gasparetto, C.
    Warsi, G.
    Ondovik, M.
    Mukhopadhyay, S.
    Paley, C.
    Schlossman, R.
    HAEMATOLOGICA, 2012, 97 : 338 - 338
  • [47] BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE IN RELAPSED MULTIPLE MYELOMA
    Villa, M. R.
    Gagliardi, A.
    Della Cioppa, P.
    Esposito, M.
    Lucania, A.
    Izzo, G. Nitrato
    Improta, S.
    Mastrullo, L.
    HAEMATOLOGICA, 2016, 101 : S114 - S114
  • [48] Elotuzumab in combination with bortezomib in patients with relapsed/refractory multiple myeloma: A phase I study.
    Jakubowiak, A. J.
    Benson, D. M., Jr.
    Bensinger, W.
    Siegel, D. S.
    Zimmerman, T. M.
    Mohrbacher, A.
    Richardson, P. G.
    Afar, D.
    Singhal, A. K.
    Anderson, K. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Elotuzumab In Combination with Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma: Updated Results of a Phase 1 Study.
    Jakubowiak, Andrzej J.
    Benson, Don M., Jr.
    Bensinger, William
    Siegel, David S.
    Zimmerman, Todd M.
    Mohrbacher, Ann
    Richardson, Paul G.
    Afar, Daniel E. H.
    Singhal, Anil K.
    Anderson, Kenneth C.
    BLOOD, 2010, 116 (21) : 1245 - 1245
  • [50] Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
    Victoria Mateos, Maria
    Prosper, Felipe
    Martin Sanchez, Jesus
    Ocio, Enrique M.
    Oriol, Albert
    Motllo, Cristina
    Michot, Jean-Marie
    Jarque, Isidro
    Iglesias, Rebeca
    Sole, Maria
    Martinez, Sara
    Kahatt, Carmen
    Fudio, Salvador
    Corral, Gema
    Zeaiter, Ali
    Montilla, Lola
    Ribrag, Vincent
    CANCER MEDICINE, 2023, 12 (04): : 3999 - 4009
12345